WEST virginia legislature
2023 regular session
Introduced
Senate Bill 45
By Senator Rucker
[Introduced January 11, 2023; referred to
the Committee on Health and Human Resources; and then to the Committee on Finance]
A BILL to amend the Code of West Virginia, 1931, as amended, by adding thereto a new section, designated §5-16-7h; to amend said code by adding thereto a new section, designated §9-5-29; to amend said code by adding thereto a new section, designated §33-15-4x; to amend said code by adding thereto a new section, designated §33-16-3ii; to amend said code by adding thereto a new section, designated §33-24-7x; to amend said code by adding thereto a new section, designated §33-25-8u; and to amend said code by adding thereto a new section, designated §33-25A-8x, all relating to requiring coverage for certain conditions; requiring coverage treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections; requiring coverage for treatment of pediatric acute onset neuropsychiatric syndrome; requiring a prior authorization to be obtained; and requiring that a physician demonstrate that all other treatments have been exhausted.
Be it enacted by the Legislature of West Virginia:
Notwithstanding any other provision of this code, a plan issued or renewed under this article after January 1, 2024, the coverage for intravenous immunoglobulin therapy for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome and other autoimmune encephalopathies shall only be covered if the insured’s physician obtains prior authorization by showing that all other treatments have been exhausted.
Notwithstanding any other provision of this code, a plan issued or renewed under this article after January 1, 2024, the coverage for intravenous immunoglobulin therapy for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome and other autoimmune encephalopathies shall only be covered if the insured’s physician obtains prior authorization by showing that all other treatments have been exhausted.
Notwithstanding any other provision of this code, a plan issued or renewed under this article after January 1, 2024, the coverage for intravenous immunoglobulin therapy for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome and other autoimmune encephalopathies shall only be covered if the insured’s physician obtains prior authorization by showing that all other treatments have been exhausted.
Notwithstanding any other provision of this code, a plan issued or renewed under this article after January 1, 2024, the coverage for intravenous immunoglobulin therapy for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome and other autoimmune encephalopathies shall only be covered if the insured’s physician obtains prior authorization by showing that all other treatments have been exhausted.
Notwithstanding any other provision of this code, a plan issued or renewed under this article after January 1, 2024, the coverage for intravenous immunoglobulin therapy for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome and other autoimmune encephalopathies shall only be covered if the insured’s physician obtains prior authorization by showing that all other treatments have been exhausted.
Notwithstanding any other provision of this code, a plan issued or renewed under this article after January 1, 2024, the coverage for intravenous immunoglobulin therapy for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome and other autoimmune encephalopathies shall only be covered if the insured’s physician obtains prior authorization by showing that all other treatments have been exhausted.
Notwithstanding any other provision of this code, a plan issued or renewed under this article after January 1, 2024, the coverage for intravenous immunoglobulin therapy for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome and other autoimmune encephalopathies shall only be covered if the insured’s physician obtains prior authorization by showing that all other treatments have been exhausted.